INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/16/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
AUREGEN BIOTHERAPEUTICS
ST13
US500000079214833Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Holders
Representatives
Gary D. Krugman Sughrue Mion, PLLC
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological implants, namely, a vital processed human or animal connective tissue; biological tissue for implantation; cells for medical use; human tissue for allografts; living cells for medical use; implants comprised of living tissue for guided tissue regeneration; implants comprising living tissue; implantable materials comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants composed of living tissue; vascular grafts being living tissue; biological molecules to assist with the development of tissue, namely, peptides, polypeptides, nucleosides, amino acids; natural biomaterials for bone and tissue augmentation for medical use; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; surgical implants comprising living tissues; biological tissue cultures for medical purposes, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
Class 9
Laboratory apparatus for the manufacture of living tissue and three-dimensional organs, namely, incubators and cell culture apparatus for laboratory use for the manufacture of living tissue and three dimensional organs; laboratory apparatus specially adapted for scientific research performed in laboratories for the manufacture of living tissue and three dimensional organs; bioreactors for cell culture; print heads for ink-jet printers; laboratory equipment for scientific use and research, namely, systems comprising a liquid distributor, an imaging facility being medical imaging equipment, related control software, and related analysis software, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
Class 40
3D printing services; 3D printing services, namely, customized creation of three-dimensional parts using rapid prototyping equipment; 3D biological printing services; biological 3D printing services
Class 42
Technical research in the field of biomaterials, 3D bioprinting and tissue engineering; three-dimensional biological printing research; tissue engineering research; scientific and medical research and development in the field of bioprinting; research and development of 3D processes and technology; scientific services relating to the isolation and cultivation of human tissues and cells, excluding services used for a diagnosis; scientific and medical research and development in the field of the manufacture of tissue; development and culture of artificial tissue and cells in the nature of tissue engineering; tissue engineering services; industrial analysis and research services in the field of tissue engineering, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
Class 44
Medical services in the field of cellular immunotherapy and transplant, excluding services used for a diagnosis; human cell and tissue bank services; medical services regarding the collection and preservation of cells for medical use, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
History of USPTO decisions and trademark events.
36 publications found
TOTAL INVALIDATION PROCESSED BY THE IB
04/16/2026
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/30/2026
INVALIDATION PROCESSED
03/30/2026
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/07/2025
CANCELLED SECTION 71
02/07/2025
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/24/2023
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/14/2019
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/14/2019
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2018
FINAL DISPOSITION NOTICE SENT TO IB
11/06/2018
FINAL DISPOSITION PROCESSED
11/06/2018
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/24/2018
REGISTERED-PRINCIPAL REGISTER
07/24/2018
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/19/2018
LIMITATION OF GOODS RECEIVED FROM IB
06/15/2018
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/08/2018
PUBLISHED FOR OPPOSITION
05/08/2018
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/18/2018
APPROVED FOR PUB - PRINCIPAL REGISTER
03/30/2018
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/23/2018
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/16/2018
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/16/2018
TEAS/EMAIL CORRESPONDENCE ENTERED
03/14/2018
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/14/2018
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/14/2018
LIMITATION OF GOODS RECEIVED FROM IB
12/22/2017
REFUSAL PROCESSED BY IB
10/07/2017
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/16/2017
REFUSAL PROCESSED BY MPU
09/16/2017
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/13/2017
NON-FINAL ACTION WRITTEN
09/12/2017
APPLICATION FILING RECEIPT MAILED
09/05/2017
ASSIGNED TO EXAMINER
08/31/2017
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2017
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/25/2017
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/24/2017
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.